XLV Health Care Select Sector SPDR Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
11:26
Sep 02
Dorian Carrell Head of Multi-Asset Income, Schroders Bloomberg Markets
Diversify away from concentrated AI assets.
Mainstream asset classes are increasingly concentrated in the same AI driver; investors can diversify into regional markets such as Europe and Japan, and areas like industrials, healthcare and convertible bonds, which have different drivers and less AI concentration.
XLV 1ST
MED
23:47
Sep 01
Jim Cramer Host, Mad Money CNBC
Healthcare acts defensive and levitates.
Cramer is shifting into healthcare because the group levitates regardless of macro or AI selling; he wants more healthcare exposure as a defensive replacement for data centers.
XLV
MED
23:40
Sep 01
Jim Cramer Host, Mad Money CNBC
Favor healthcare over data centers.
Cramer wants to slim data center exposure because data centers are a major political battleground and could remain unpopular into the November election; he is replacing it with healthcare, which he says levitates regardless of the macro, and may buy data centers back after the election.
XLV
HIGH
18:32
Sep 01
Josh Brown CEO, Ritholtz Wealth Management CNBC
Momentum cool-off is healthy for equities
He argues the momentum unwind has been happening all summer and is healthy: momentum peaked relative to the S&P on June 22 and is down 13.7% since then, while broad waves of non-momentum stocks, including health care and energy, have picked up the slack; he would not make tactical seasonal sales.
XLV
HIGH
16:57
Sep 01
Scott Chronert Managing Director, Citi Bloomberg Markets
Rotation favors less-loved S&P segments.
The AI trade needs broadening; the Mag 7 has lost market relevancy and underperformed, while areas like consumer discretionary and health care have not yet participated and still have room to be priced in.
XLV 1ST
MED
16:11
Sep 01
ces921 Author, The Aletheia Narrative (Substack)
The author provides a macro market analysis highlighting inflation-driven Fed tightening.
The author provides a macro market analysis highlighting inflation-driven Fed tightening, momentum-chasing in tech, credit deterioration, and energy divergence, but makes no explicit personal position or forward call on any ticker.
XLV
05:55
Sep 01
XLV called safe, no catalyst
XLV called safe in a reply about smaller-capital healthcare exposure; no specific catalyst or directional view.
XLV
LOW
05:25
Sep 01
XLV top holdings shown, no view stated
Author clarifies a prior post was merely displaying XLV's top holdings, with no directional stance or recommendation expressed.
XLV
LOW
05:12
Sep 01
Buy XLV on healthcare uptrend setup
Buy XLV for healthcare exposure as the sector starts to set up again and remains in a strong uptrend.
XLV
MED
17:53
Aug 31
Rotate from high-beta AI to defensive sectors.
Nvidia earnings failed to restart momentum; Micron, Corning, and Marvell did not catch a bid, so momentum funds are getting confirmation to rotate away from high-beta AI exposure and into healthcare, energy, and commodities as positioning shifts into September/October.
XLV 1ST
HIGH
10:00
Aug 31
Former President Trump ("Mango") is scheduled to speak about healthcare policy at 3 PM. Political speeches regarding specific sectors often cause short-term speculative capital rotation into those sectors. Buy healthcare stocks/ETFs ahead of the speech to capture the momentum from the policy discussion. The speech may lack actionable policy details, resulting in a "sell the news" event or no movement at all.
XLV 1ST
LOW
20:47
Aug 28
Pharma pricing power remains strong
Nela Richardson says no one is escaping the elephant in the market: healthcare costs are climbing. Revolutionary drugs such as GLP-1 obesity treatments and cancer therapies come with high price tags, and pharmaceuticals have a 7-8 year window to recoup costs, so employers and employees must pay up for next-level care.
XLV
MED
22:03
Aug 27
Stephanie Guild Chief Investment Officer, Robinhood Bloomberg Markets
AI discoveries will drive healthcare sector growth.
The healthcare sector is well-positioned to benefit from AI discoveries, as AI helps connect specialized medical data that human specialists might miss.
XLV
MED
11:06
Aug 27
Lee Ji-hwan CEO, Aurora Investment Advisory 3PRO TV (삼프로TV)
Trade healthcare stocks strictly short-term.
Healthcare and biotech stocks are currently rising on the illusion of rate cuts and quantitative easing. However, since the actual trend post-election will be a rate hike cycle, these should be traded strictly short-term.
XLV
MED
14:59
Aug 26
Keith Lerner Chief Investment Officer, Truist Wealth CNBC
Upgraded healthcare; positive trials, AI support.
Truist upgraded healthcare, supported by positive clinical trials and drug development, and healthcare likely benefits from AI.
XLV 1ST
MED
13:30
Aug 25
Lee Ji-hwan CEO, Aurora Investment Advisory 3PRO TV (삼프로TV)
Trade biotech strictly as short-term plays.
If US Treasury yields drop temporarily due to the Treasury's use of the TGA account, rate-cut sensitive sectors like biotech and pharma will benefit. However, this is only a short-term window before potential rate hikes or normalization, so they should be traded strictly as short-term hit-and-run plays.
XLV
MED
23:37
Aug 24
Jim Cramer Host, Mad Money CNBC
Rotate into defensive non-data-center stocks
Money is rotating out of data center names into non-data-center groups such as Procter & Gamble, Coca-Cola, UnitedHealth, JPMorgan and Target; healthcare and travel/leisure also work because people want out of data centers and these are convenient places to put money.
XLV
HIGH
19:26
Aug 24
Ryan Detrick Chief Market Strategist, Carson Group CNBC
Overweight tech, financials, industrials, health care.
He favors technology, financials, industrials, and health care because the economy is turning the corner, regional surveys and earnings have been strong, and leadership can rotate, with health care already showing momentum last week.
XLV 1ST
HIGH
14:20
Aug 23
seedy19tron Biotech trader, L/S
A factual recap of biotech and pharma fund performance in July 2026.
A factual recap of biotech and pharma fund performance in July 2026, with sector data but no personal positions or forward calls.
XLV
LOW
21:10
Aug 21
Roosevelt Bowman Senior Investment Strategist, Bernstein Private Wealth Management CNBC
Position defensively in staples and healthcare
By the end of the year, headline inflation is likely to outpace wage growth for the first time in four years, causing slower consumption; therefore clients are positioned more defensively in consumer staples and health care, which tend to do well in a slowing economy.
XLV 1ST
HIGH
19:30
Aug 21
Stephanie Guild Chief Investment Officer, Robinhood Bloomberg Markets
Healthcare offers stability and AI upside potential.
Healthcare offers stability in a market where debt-fueled growth is causing wobbles, and the sector is poised to phenomenally benefit from AI advancements.
XLV
MED
04:32
Aug 21
Healthcare offers cheap growth and AI diversification.
The global healthcare sector has turned the corner by controlling costs and returning to growth at cheap valuations, offering excellent diversification away from AI disruption risks.
XLV 1ST
HIGH
22:00
Aug 20
Mark Newton Managing Director and Head of Technical Strategy at Fundstr… CNBC
Health care is breaking out; long sector.
Health care broke out of a nearly three-year downtrend. Drug pricing and ACA subsidy concerns have turned, biotech is surging, deals are happening across biotech, pharma, and HMOs, and GLP-1 helps pharma stocks.
XLV 1ST
HIGH
19:10
Aug 20
Rick Rieder CIO of Global Fixed Income at BlackRock CNBC
Healthcare and AI offer exciting market opportunities.
The current market environment is exceptionally target-rich and exciting, with strong opportunities in healthcare, specifically citing Moderna, as well as AI beneficiaries, which could drive the broader market up another 5 to 10% this year.
XLV 1ST
HIGH
13:30
Aug 20
Lee Ji-hwan CEO, Aurora Investment Advisory 3PRO TV (삼프로TV)
Favor pharma over biotech as yields fall.
Lee expects no Federal Reserve rate hike before the November midterm elections, and with Treasury yields easing into the September FOMC, he sees the rate-sensitive pharmaceutical sector as an area to watch and buy. Biotech, by contrast, should be used as an opportunity to exit rather than as a new long.
XLV FLIP
MED
10:00
Aug 20
Felix Jauvin Co-Host, Forward Guidance Forward Guidance
AI breakthroughs make healthcare an attractive defensive rotation.
Healthcare innovation is a defensive sector that outperforms during tech rotations. Breakthroughs driven by AI adoption, such as Moderna's cancer trials and Eli Lilly's developments, make biotech and healthcare highly attractive areas for capital rotation.
XLV 1ST
MED
09:59
Aug 20
seedy19tron Biotech trader, L/S
Analyzes unprecedented biotech short squeeze market dynamics.
Mentions biotech ETFs in the context of analyzing the unprecedented short squeeze and subsequent degrossing dynamics.
XLV
LOW
00:54
Aug 20
seedy19tron Biotech trader, L/S
Highlights upcoming catalysts for healthcare sector
Points to a thread detailing upcoming August to December catalysts for the healthcare sector.
XLV
LOW
20:57
Aug 19
Labubu Trader Long-term investor
Healthcare historically outperforms in midterm second halves.
Notes that the healthcare sector has historically outperformed during the second half of midterm election years.
XLV
MED
16:54
Aug 19
Nadia Lovell UBS Global Wealth Management Bloomberg Markets
Healthcare attractive AI-free diversifier.
Healthcare is an attractive portfolio diversifier that is not tied to the AI capex story in the near term; it has been the top-performing sector over the last three months, offers innovation in GLP-1s, obesity/diabetes, and cancer, and is resuming earnings growth with valuation not extended.
XLV
MED

About XLV Analyst Coverage

Buzzberg tracks XLV (Health Care Select Sector SPDR) across 43 sources. 167 bullish vs 3 bearish calls from 159 analysts. Sentiment: predominantly bullish (68%). 240 total trade ideas tracked. Past 7 days: 10 bullish, 4 watch. Latest voices: Dorian Carrell, Jim Cramer, Josh Brown.